AI assistant
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2013
Jul 23, 2013
31580_dirs_2013-07-23_63de276e-1999-4ed8-b1f2-4acf9d6eda03.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2013-07-23
Reporting Person: Tessier-Lavigne Marc (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 45454 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.34 | 2022-12-04 | Common Stock (4363) | Direct |
Footnotes
F1: Reflects a 1-for-2.75 reverse stock split effected on July 11, 2013.
F2: This option was granted on December 4, 2012. The shares subject to such option vest in full on December 4, 2013. The option is subject to an early exercise provision, which allows the reporting person to exercise the option as to the unvested shares (in addition to the vested shares) if simultaneously with such exercise the reporting person enters into a restricted stock agreement providing the issuer with repurchase rights with respect to the unvested shares.